Double-Blind Clinical Trial of Arginine Supplementation in the Treatment of Adult Patients with Sickle Cell Anaemia
Background. Sickle cell anaemia (SCA) is the most prevalent monogenic disease in Brazil. In SCA, haemoglobin S (HbS) is formed, which modifies red blood cell morphology. Intravascular haemolysis occurs, in which free Hb and free radicals degrade nitric oxide (NO) and release arginase, which reduces...
Principais autores: | Renata M. N. Eleutério, Francisco O. Nascimento, Tamara G. Araújo, Marilena F. Castro, Tarcísio P. Almeida Filho, Pedro A. Maia Filho, José Eleutério, Darcielle B. D. Elias, Romélia P. G. Lemes |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Wiley
2019-01-01
|
coleção: | Advances in Hematology |
Acesso em linha: | http://dx.doi.org/10.1155/2019/4397150 |
Registros relacionados
-
Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
por: Alano Martins Pedrosa, et al.
Publicado em: (2014-04-01) -
L-Arginine supplementation enhanced expression of glucose transporter (GLUT 1) in sickle cell anaemia subjects in the steady state
por: W.A. Saka, et al.
Publicado em: (2023-01-01) -
SICKLE CELL ANAEMIA AND MALARIA
por: Lucio Luzzatto
Publicado em: (2012-10-01) -
Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial
por: Cox, SE, et al.
Publicado em: (2018) -
Standardization method for measurement of hydroxyurea by Ultra High Efficiency Liquid Chromatography in plasma of patients with sickle cell disease
por: Darcielle Bruna Dias Elias, et al.
Publicado em: (2014-09-01)